Mdb Capital Holdings, Llc · NASDAQ:MDBH
Mdb Capital — Q4 2025 Earnings Presentation
21 slides from Mdb Capital's earnings presentation, Mar 31, 2026
Slide 1: We Launch Game-Changing Companies
The Premier Public Venture Platform NASDAQ: MDBH We Launch Game-Changing Companies Fourth Quarter and Full Year 2025 Update March 31, 2026
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words
Slide 3: Today’s Agenda
Today’s Agenda Our Story: From Proven Model to Scalable Platform AI and Its Transformative Impact on MDB Infrastructure Assets: MDB Direct & PatentVest Portfolio Assets Gaining Momentum Financial Overview & Perspective Path Forward: Scale, Monetization & Cost/Scale Efficiency
Slide 4: Our Story: From Proven Model to Scalable Platform
Our Story: From Proven Model to Scalable Platform We went public to scale what already works Pre-IPO: Post-IPO Goal: 1 Big Idea launch every 18 months → 3–5 launches per year, 10× impact, build public founder-led, bandwidth-constrained venture portfolios of 10–12 companies 29-year track record: 18 I
Slide 5: The Evolution of Our Platform- Why We Can Scale
The Evolution of Our Platform- Why We Can Scale From phone calls to Washington D.C. to continuous process refinement Pre-Internet 2003 Internet Era Reality Physical Filing Persistent Bottleneck PatentVest Born Process Refinement Retrieval Deep diligence, regulatory Proprietary IP database Screening
Slide 6: AI Changes Everything
AI Changes Everything A significant shift perhaps more important than the Internet itself AI Guided The Internet AI By Humans Eliminates inertia. Catalogued and The human brain excels at It connects dots at organized information unprecedented speed and context and judgement. but created overload AI+
Slide 7: AI’s Transformative Impact on MDB
AI’s Transformative Impact on MDB Expert-guided AI is reshaping sourcing, diligence, and launches Sourcing – Boil the ocean in real time AI agents + our proprietary criteria scan every new patent and grant from universities, labs and government programs – work 100 analysts could never do continuousl
Slide 8: Infrastructure Investing – Years of Asset Building
Infrastructure Investing – Years of Asset Building We’ve turned operating capital into unique, valuable assets What We’ve Invested In o Two pioneering platforms that no one else has — using OpEx, not separate capital raises o Invested approximately $4 million annually since IPO in these assets o The
Slide 9: MDB Direct – A Rare, Hard Won Strategic Asset
MDB Direct – A Rare, Hard Won Strategic Asset One of the most difficult and valuable capabilities we have built Why We Built It What We Built Why It’s Rare & Valuable To scale IPOs and o CMA started 2019 → DTC economically handle Operating clearing firms approval May 2023 small $2,000 allocations ar
Slide 10: The Big Opportunity for MDB Direct
The Big Opportunity for MDB Direct Strategic partnership to monetize the asset and solve our distribution challenge at scale The Market Reality Our Advantage – Path Forward o Public venture is an individual- o Multiple large AUM firms actively seeking investor asset class. clearing capabilities o Am
Slide 11: PatentVest – The Future of IP Law in the AI Era
PatentVest – The Future of IP Law in the AI Era Going back to our roots — and forward into a billion-dollar opportunity Why We Built It What We Built Why It’s Rare & Valuable The Patent System Is o ABS law firm structure o First ABS IP Law Firm Broken (attorney-client privilege + equity incentives)
Slide 12: PatentVest Market Opportunity
PatentVest Market Opportunity Massive IP market ready for disruption Market Size & Tailwinds 600K+ $10–$15B $30B+ +50% annual US US IP PatentVest cost AI legal tech reduction while patent filings prosecution market spend improving quality Benchmark: Harvey AI funded at $11B; first independent law fi
Slide 13: Portfolio Assets Gaining Momentum
Portfolio Assets Gaining Momentum Two game-changing companies addressing the biggest healthcare opportunity of our time The Metabolic Epidemic o 2.5 billion adults are overweight with 890 million living with obesity; projected to grow to 1.13 billion by 2030 Cell-free biomanufacturing — the promise
Slide 14: eXoZymes (NASDAQ: EXOZ)
eXoZymes (NASDAQ: EXOZ) Cell-free biomanufacturing — the promise of synthetic biology, finally realized The Investment Thesis o Cell-free biomanufacturing is the future of ~4.1M Shares/warrants held by MDB synthetic biology — and we believe EXOZ will Current position be one of its leaders o Ginkgo B
Slide 15: Paulex Bio (Private)
Paulex Bio (Private) Beta cell regeneration for Diabetes — Potentially the most impactful drug we have ever launched The Science & Strategy Major Milestones o A pill that stimulates production of insulin- Q4 2025 producing beta cells — potential Type 1 and Type 2 diabetes breakthrough $19M seed roun
Slide 16: Our Four Principal Assets
Our Four Principal Assets Tangible value today — and the upside potential we are working to realize Asset MDB Position Current / Book Value Upside Scenario Status eXoZymes ~4.1M shares + Potential $B+ if cell- ~$30M at market Active / Public (EXOZ) warrants free mfg scales ~7.1M shares + ~$8M* post
Slide 17: Financial Overview
Financial Overview Value creation beyond the cash P&L ~$10M ~$5.7M ~$22.3M ~$4M Cash, Current Assets, Investment in Clearing Annual Fixed OpEx Net Cash Used (FY25) Marketable Securities less Platform and PatentVest All Liabilities Development from OpEx Current run rate Below baseline due to deal fee
Slide 18: Risk Factors & Honest Acknowledgments
Risk Factors & Honest Acknowledgments No sure things, but a plan, a team, and a clear view of the road ahead Macro & Global Risk Microcap Market Conditions Geopolitical instability and macro uncertainty could The microcap market remains difficult; liquidity and negatively impact microcap valuations
Slide 19: Path Forward: Scale, Monetization & Lower Costs
Path Forward: Scale, Monetization & Lower Costs AI + Strategic Assets = More Launches, Less Expense, Greater Value o Now positioned to offer 3–5 high-quality launches per year with greater depth o Clearing partnership/sale can expand retail distribution reach o PatentVest spin-out monetizes IP platf
Slide 20: Faith that we can make a positive difference is what drives us every day.
MDB CAPITAL HOLDINGS Faith that we can make a positive difference is what drives us every day. Thank you for your faith in us at MDB. © MDB Capital Holdings 2026. All Rights Reserved. 13 / 14
Slide 21: Questions?
MDB CAPITAL HOLDINGS Questions? 13 / 14